© 2021 MJH Life Science and Nutrition Outlook. all rights reserved.
© 2021 MJH Life Sciences™ and Nutrition Outlook. all rights reserved.
The company stated that the beta-alanine market is ready to grow as consumers are increasingly concerned about health and wellness following the COVID-19 pandemic.
Mark LeDoux, CEO and Chairman of the Board of Natural Alternatives International Inc. (NAI), said that as consumers pay more attention to health and wellness following the COVID-19 pandemic, the beta-alanine market is ready to grow; Carlsbad, California Germany), during the SupplySide West trade show. This bodes well for NAI's flagship CarnoSyn and SR CarnoSyn β-alanine ingredients. LeDoux said that he expects significant growth in the sports nutrition and healthy aging market in the future.
"CarnoSyn has performed well recently," LeDoux said on the show. "I think it will only start again." LeDoux said that, like many sports nutrition ingredients, CarnoSyn's sales fell last year when the gym was closed, but it didn't last long. He said: "Once the gym starts to open in different venues, our revenue will grow again very well, and we think it will only grow."
SR CarnoSyn has a promising market for healthy aging. It is a slow-release version of CarnoSyn, designed for the healthy aging market, providing benefits for muscle function, brain health, heart health, bone health, and general health.
Consumers are paying more and more attention to health and wellness after COVID, which is a boon for SR CarnoSyn. "The use of materials in healthy living spaces is really interesting," LeDoux said. "We think it will gain some important momentum in the next year. We think that as far as SR CarnoSyn is concerned, the 2022 calendar year will be very striking."
The world’s aging population will play a role, and so will the pandemic. Ledoux said that one of the things caused by the pandemic-"almost global"-"reinforces people's intuition that taking supplements is not a luxury; it is a necessity."
Part of NAI's current focus is to expand the delivery format of SR CarnoSyn to include tablets and powders.
The contract manufacturing aspect of the NAI business is experiencing the same overwhelming growth as the entire dietary supplement industry, especially during the pandemic. LeDoux said that since the beginning of the pandemic, NAI's sales have "increased by 100%."
"I mean, our forecast for this year is almost meaningless at this point because we took this snapshot three months ago," he added. "When we release earnings within a few weeks, we will have to make adjustments again."
In other words, like companies inside and outside the supplement industry, NAI is not immune to global labor shortages and supply chain issues. But LeDoux said his team is solving the challenge.
"Every supplement supplier I have spoken to in the past few weeks is facing the same problem," he said. “It’s not a lack of materials, although there are some shortages of seasonal and hard-to-obtain raw materials. It’s just a shortage of manpower. Insufficient staff. Now, if you work 5 days a week, 9-5 days a day, you may be doing quite well, but You have not experienced the growth that most industries in our region are experiencing. For the foreseeable future, we can run our factories 24/7 and we may catch up in about 9 months. This is reality."
Between NAI's facilities, including Carlsbad, California and Switzerland, the company employs hundreds of employees. It also plans to open a new factory next year, which LeDoux said "will produce products worth millions of dollars." Currently, the company is seeking to provide employment opportunities for veterans repatriated from the United States, and may temporarily transfer some employees between different locations, including employees from Switzerland. "Our advantage is that we have a very good factory in Switzerland, and they have no labor shortage in Switzerland," LeDoux said. "In fact, we have surplus labor."